Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples